Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD201520162017201820192020
Revenues--341m394m--
% growth---16 %--
EBITDA--5.0m52.0m68.0m86.0m
% EBITDA margin--1 %13 %--
Profit--(3.0m)25.0m58.0m67.0m
% profit margin--(1 %)6 %--
R&D budget60.5m67.1m61.6m64.9m--
R&D % of revenue--18 %16 %--

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

N/A

IPO

$2.8b

Valuation: $2.8b

7.1x EV/LTM Revenues

53.8x EV/LTM EBITDA

Acquisition
Total Funding-

Recent News about Genomic Health

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Genomic Health

Edit
InVitae
ACQUISITION by LabCorp Aug 2024